Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on May 13, 2021 on account of Id-Ul-Fitr (Ramzan Id).

Markets end 0.7% down for the week
Fri, 7 Feb Closing

Indian equity markets started the day on a positive note on firm global cues but turned volatile post noon session before finally closing the day in the green. Pharma and Metal stocks were the biggest gainers. While the BSE Sensex closed higher by 65 points, the NSE-Nifty closed higher by 26 points. BSE Mid Cap and the BSE Small Cap closed on a positive note.

As regards global markets, Asian indices closed in the green. European indices have also opened firm. The rupee was trading at Rs 62.4 to the dollar at the time of writing.

Cadila Healthcare Ltd has announced its results for the quarter ended December 2013. Consolidated net profit grew by 81.5% YoY helped by lower interest cost and taxation. The consolidated net sales also moved up by 17.8%. EBDITA increased by 16.9%. Cadila's business in the US registered a growth of 61%, while the emerging markets business grew by 30%. The company filed 31 additional ANDAs with the USFDA taking the cumulative ANDA filings for the period April-December 2013 to 49. For the nine months period ended December 2013, Cadila's consolidated net sales increased by 12.2%.

The Supreme Court of India (SC) has directed National Thermal Power Corporation (NTPC) to continue supplying power to Reliance controlled BSES Rajdhani Power Ltd and BSES Yamuna Power Ltd till March 26. SC has directed the discoms to pay Rs 500 m to NTPC as a part payment of its outstanding dues within two weeks. Hearing the petition by the two Reliance discoms, the court issued notice to the central and Delhi governments, the Delhi Electricity Regulatory Commission and NTPC, asking them to respond to the Reliance plea within two weeks and gave another one week to the discoms to file their rejoinders. The move comes against the backdrop of the Delhi government's recommendation to the regulator for revocation of the licenses issued to the two firms if they failed to pay their dues to NTPC and/or resort to long power outages in the city.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Markets end 0.7% down for the week". Click here!

  

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


May 12, 2021 (Close)

S&P BSE HEALTHCARE 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS